(PharmaNewsWire.Com, September 08, 2021 ) According to the new market research report "Tracheostomy Products Market by Product (Tracheostomy Tube (Double Lumen, Cuffed, Fenestrated), Accessories), Technique (Ciaglia Blue Rhino, Translaryngeal, Percutwist, Shachner/Rapitrac, Translaryngeal/Fantoni), End-User, Region - Global Forecast to 2024", MarketsandMarkets: The tracheostomy products market size is projected to reach USD 220 million by 2024 from USD 179 million in 2019, at a CAGR of 4.2%.
Browse and in-depth TOC on "Tracheostomy Products Market" 102 - Tables 32 - Figures 162 - Pages
The major factors driving the growth of the tracheostomy products market are the availability of clinical evidence for their safety & efficacy and increasing adoption of tracheostomy procedures among medical professionals owing to procedural benefits offered by tracheostomy products. Moreover, the rising demand for home care services is expected to play a significant role in fueling market growth.
Tracheostomy tubes segment accounted for the largest share of the tracheostomy products market, by type, in 2018
The tracheostomy tubes segment held the largest share of the tracheostomy products industry in 2018. The large share of this segment can be attributed to the procedural and technical benefits offered, such as the ability to pass suctioning catheters or fiberoptic devices into the collapsed area, rapid placement, fast lung isolation, and non-requirement for bronchoscopy in placement.
Ciaglia blue rhino tracheostomy segment to register the highest growth in the tracheostomy products market, by technique, during the forecast period
The ciaglia blue rhino tracheostomy segment is expected to grow at the highest CAGR during the forecast period. Growth in this market can primarily be attributed to procedural benefits offered, such as the low risk of damage to the membranous tracheal wall and rapid insertion (owing to the passage of a single dilator). Furthermore, the market growth is driven by favorable reimbursement scenario & medical insurance coverage and the availability of clinical evidence for their safety & efficacy.
Hospitals & surgical centers segment accounted for the largest share of the tracheostomy products market, by the end-user, in 2018
Hospitals & surgical centers were the largest application segment of the tracheostomy products industry, and this trend is expected to continue during the forecast period. A large number of private enterprises are taking steps to cater to the needs of modern, which has resulted in the large share of this segment. Other significant factors include well-equipped state-run healthcare facilities in these regions and growing healthcare consolidation to improve access to healthcare services.
North America dominates the tracheostomy products market
The market is segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the market in 2018. Factors such as the presence of a highly developed healthcare system, an increasing number of emergency department visits, high adoption of innovative tracheostomy devices among medical professionals, and wide availability of advanced tracheostomy devices are driving the market for tracheostomy products in North America.
The major players operating in the tracheostomy products market are Medtronic plc (Ireland), Smiths Group plc (UK), TRACOE Medical GmbH (Germany), Teleflex Incorporated (US), and Fisher & Paykel Healthcare Ltd. (New Zealand). Other prominent players operating in this market include ConvaTec Group (US), Cook Group (US), Troge Medical GmbH (Germany), Well Lead Medical Co., Ltd. (US), Fuji Systems Corporation (Japan), Andreas Fahl Medizintechnik-Vertrieb GmbH (Germany), Xinxiang Huaxi Sanitary Materials Co., Ltd. (China), Medis Medical (Tianjin) Co. Ltd. (China), Boston Medical (US), and Pulmodyne (US).
ENT Devices Market by product (Diagnostic (Endoscope, Hearing Screening Devices), Surgical Devices, (Powered Surgical Instruments, ENT Supplies, Ear Tubes), Hearing Aids, CO2 Lasers, & End Users (Hospital & ASCs, ENT Clinics)- Global Forecast to 2026 <||>rnhttps://www.marketsandmarkets.com/Market-Reports/ent-devices-market-150060281.html
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
